Allyl bromide → HCID 54226836, compound
Reaction equation
C(N(C(C)C)[CH:4]([CH3:6])[CH3:5])C.[CH2:10](Br)[CH:11]=[CH2:12].[NH2:14][CH2:15][C:16]1[O:20][N:19]=[C:18]([C:21]2[N:22]=[CH:23][N:24]3[C:30]4[CH:31]=[CH:32][C:33]([F:36])=[C:34]([F:35])[C:29]=4[C:28](=[O:37])[N:27]4[CH2:38][CH2:39][C@H:26]4[C:25]=23)[N:17]=1>C(Cl)Cl>[CH2:10]([N:14]([CH2:15][C:16]1[O:20][N:19]=[C:18]([C:21]2[N:22]=[CH:23][N:24]3[C:30]4[CH:31]=[CH:32][C:33]([F:36])=[C:34]([F:35])[C:29]=4[C:28](=[O:37])[N:27]4[CH2:38][CH2:39][CH:26]4[C:25]=23)[N:17]=1)[CH2:6][CH:4]=[CH2:5])[CH:11]=[CH2:12]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
2.3 ml (13.5 mmol) of N-ethyldiisopropylamine and 0.66 ml (7.8 mmol) of allyl bromide were added to a solution of 700 mg (1.95 mmol) of (S)-1-(5-aminomethyl-1,2,4-oxadiazol-3-yl)-7,8-difluoro-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one in 40 ml of methylene chloride and the mixture was stirred at room temperature for 20 hours. The reaction solution was diluted with methylene chloride and washed three times with water. The organic phases were dried over magnesium sulfate, filtered and evaporated. The residue obtained was chromatographed (silica gel, methylene chloride/methanol 19:1). There were obtained 400 mg (46%) of S)-1-[5-(diallylaminomethyl)-1,2,4-oxadiazol-3-yl]-7,8-difluoro-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one as a colourless foam, Rf=0.17 (silica gel, methylene chloride/methanol 19:1).
Workup
- washwashed three times with water
- dry with materialThe organic phases were dried over magnesium sulfate
- filtrationfiltered
- customevaporated
- customThe residue obtained
- customwas chromatographed (silica gel, methylene chloride/methanol 19:1)
Sources & evidence
- ORD record
- ord-ecfd39a27c7547d89b71a84614f00437
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05665718
Reaction notes
Loading…